Glypican-1 regulates myoblast response to HGF via Met in a lipid raft-dependent mechanism: Effect on migration of skeletal muscle precursor cells

Skeletal Muscle

Volumn 4, Issue 1, 2014, Pages

  Gutiérrez, Jaime ^a   Cabrera, Daniel ^a   Brandan, Enrique ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Glypican 1; Heparan sulfate proteoglycans; Hepatocyte growth factor; HGF mediated signaling; Raft membrane domains; Skeletal muscle

Indexed keywords

EID: 84894059782     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/2044-5040-4-5     Document Type: Article

References (91)

1. Ciciliot S, Schiaffino S. Regeneration of mammalian skeletal muscle: basic mechanisms and clinical implications. Curr Pharm Des 2010, 16:906-914. 10.2174/138161210790883453, 20041823.
2. Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 2010, 120:11-19. 10.1172/JCI40373, 2798695, 20051632.
3. Gal-Levi R, Leshem Y, Aoki S, Nakamura T, Halevy O. Hepatocyte growth factor plays a dual role in regulating skeletal muscle satellite cell proliferation and differentiation. Biochim Biophys Acta 1998, 1402:39-51. 10.1016/S0167-4889(97)00124-9, 9551084.
4. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987, 327:239-242. 10.1038/327239a0, 2952888.
5. Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, Narsimhan RP, Hartmann G, Zarnegar R, Michalopoulos GK, Birchmeier W, Comoglio PM. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 1991, 10:2867-2878. 452997, 1655405.
6. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 1995, 376:768-771. 10.1038/376768a0, 7651534.
7. Birchmeier C, Bladt F, Yamaai T. The functions of HGF/SF and its receptor, the c-Met tyrosine kinase, in mammalian development. Ciba Found Symp 1997, 212:169-182.
8. Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998, 8:404-410. 10.1016/S0962-8924(98)01359-2, 9789329.
9. Sheehan SM, Allen RE. Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J Cell Physiol 1999, 181:499-506. 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1, 10528236.
10. Sheehan SM, Tatsumi R, Temm-Grove CJ, Allen RE. HGF is an autocrine growth factor for skeletal muscle satellite cells in vitro. Muscle Nerve 2000, 23:239-245. 10.1002/(SICI)1097-4598(200002)23:2<239::AID-MUS15>3.0.CO;2-U, 10639617.
11. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 1993, 123:223-235. 10.1083/jcb.123.1.223, 2119804, 8408200.
12. Sonnenberg E, Weidner KM, Birchmeier C. Expression of the met-receptor and its ligand, HGF-SF during mouse embryogenesis. EXS 1993, 65:381-394.
13. Jennische E, Ekberg S, Matejka GL. Expression of hepatocyte growth factor in growing and regenerating rat skeletal muscle. Am J Physiol 1993, 265:C122-C128.
14. Sipeki S, Bander E, Buday L, Farkas G, Bácsy E, Ways DK, Faragó A. Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering. Cell Signal 1999, 11:885-890. 10.1016/S0898-6568(99)00060-1, 10659996.
15. Zhang YW, Vande Woude GF. HGF/SF-met signaling in the control of branching morphogenesis and invasion. J Cell Biochem 2003, 88:408-417. 10.1002/jcb.10358, 12520544.
16. Goyal L, Muzumdar MD, Zhu AX. Targeting the HGF/c-MET pathway in hepatocellular carcinoma. Clin Cancer Res 2013, 19:2310-2318. 10.1158/1078-0432.CCR-12-2791, 23388504.
17. Ghatak S, Hascall VC, Markwald RR, Misra S. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor. J Biol Chem 2010, 285:19821-19832. 10.1074/jbc.M110.104273, 2888393, 20200161.
18. Singleton PA, Salgia R, Moreno-Vinasco L, Moitra J, Sammani S, Mirzapoiazova T, Garcia JG. CD44 regulates hepatocyte growth factor-mediated vascular integrity: role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin. J Biol Chem 2007, 282:30643-30657. 10.1074/jbc.M702573200, 17702746.
19. Seveau S, Bierne H, Giroux S, Prévost MC, Cossart P. Role of lipid rafts in E-cadherin- and HGF-R/Met-mediated entry of Listeria monocytogenes into host cells. J Cell Biol 2004, 166:743-753. 10.1083/jcb.200406078, 2172418, 15337781.
20. Hung CM, Kuo DH, Chou CH, Su YC, Ho CT, Way TD. Osthole suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition via repression of the c-Met/Akt/mTOR pathway in human breast cancer cells. J Agric Food Chem 2011, 59:9683-9690. 10.1021/jf2021489, 21806057.
21. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 2002, 16:3074-3086. 10.1101/gad.242602, 187488, 12464636.
22. Knudson W, Chow G, Knudson CB. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol 2002, 21:15-23. 10.1016/S0945-053X(01)00186-X, 11827788.
23. Villena J, Brandan E. Dermatan sulfate exerts an enhanced growth factor response on skeletal muscle satellite cell proliferation and migration. J Cell Physiol 2004, 198:169-178. 10.1002/jcp.10422, 14603519.
24. Lyon M, Deakin JA, Mizuno K, Nakamura T, Gallagher JT. Interaction of hepatocyte growth factor with heparan sulfate: elucidation of the major heparan sulfate structural determinants. J Biol Chem 1994, 269:11216-11223.
25. Lyon M, Gallagher JT. Hepatocyte growth factor/scatter factor: a heparan sulphate-binding pleiotropic growth factor. Biochem Soc Trans 1994, 22:365-370.
26. Ashikari S, Habuchi H, Kimata K. Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor. J Biol Chem 1995, 270:29586-29593. 10.1074/jbc.270.49.29586, 7494002.
27. Catlow KR, Deakin JA, Wei Z, Delehedde M, Fernig DG, Gherardi E, Gallagher JT, Pavão MS, Lyon M. Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density. J Biol Chem 2008, 283:5235-5248.
28. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999, 68:729-777. 10.1146/annurev.biochem.68.1.729, 10872465.
29. Bernfield M, Hooper KC. Possible regulation of FGF activity by syndecan, an integral membrane heparan sulfate proteoglycan. Ann NY Acad Sci 1991, 638:182-194. 10.1111/j.1749-6632.1991.tb49029.x, 1785801.
30. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991, 64:841-848. 10.1016/0092-8674(91)90512-W, 1847668.
31. Larraín J, Carey DJ, Brandan E. Syndecan-1 expression inhibits myoblast differentiation through a basic fibroblast growth factor-dependent mechanism. J Biol Chem 1998, 273:32288-32296. 10.1074/jbc.273.48.32288, 9822708.
32. Fuentealba L, Carey DJ, Brandan E. Antisense inhibition of syndecan-3 expression during skeletal muscle differentiation accelerates myogenesis through a basic fibroblast growth factor-dependent mechanism. J Biol Chem 1999, 274:37876-37884. 10.1074/jbc.274.53.37876, 10608853.
33. Rapraeger AC, Krufka A, Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 1991, 252:1705-1708. 10.1126/science.1646484, 1646484.
34. van der Voort R, Taher TE, Wielenga VJ, Spaargaren M, Prevo R, Smit L, David G, Hartmann G, Gherardi E, Pals ST. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem 1999, 274:6499-6506. 10.1074/jbc.274.10.6499, 10037743.
35. Brandan E, Carey DJ, Larraín J, Melo F, Campos A. Synthesis and processing of glypican during differentiation of skeletal muscle cells. Eur J Cell Biol 1996, 71:170-176.
36. Campos A, Núñez R, Koenig CS, Carey DJ, Brandan E. A lipid-anchored heparan sulfate proteoglycan is present in the surface of differentiated skeletal muscle cells: isolation and biochemical characterization. Eur J Biochem 1993, 216:587-595. 10.1111/j.1432-1033.1993.tb18178.x, 8397086.
37. Larraín J, Alvarez J, Hassell JR, Brandan E. Expression of perlecan, a proteoglycan that binds myogenic inhibitory basic fibroblast growth factor, is down regulated during skeletal muscle differentiation. Exp Cell Res 1997, 234:405-412. 10.1006/excr.1997.3648, 9260911.
38. Gutiérrez J, Brandan E. A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation. Mol Cell Biol 2010, 30:1634-1649. 10.1128/MCB.01164-09, 2838066, 20100867.
39. Gutierrez J, Osses N, Brandan E. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2. J Cell Physiol 2006, 206:58-67. 10.1002/jcp.20428, 15920756.
40. Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977, 270:725-727. 10.1038/270725a0, 563524.
41. Osses N, Gutierrez J, Lopez-Rovira T, Ventura F, Brandan E. Sulfation is required for bone morphogenetic protein 2-dependent Id1 induction. Biochem Biophys Res Commun 2006, 344:1207-1215. 10.1016/j.bbrc.2006.04.029, 16647687.
42. Osses N, Brandan E. ECM is required for skeletal muscle differentiation independently of muscle regulatory factor expression. Am J Physiol Cell Physiol 2002, 282:C383-C394. 10.1152/ajpcell.00322.2001, 11788350.
43. Droguett R, Cabello-Verrugio C, Riquelme C, Brandan E. Extracellular proteoglycans modify TGF-β bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol 2006, 25:332-341. 10.1016/j.matbio.2006.04.004, 16766169.
44. Lafreniere JF, Mills P, Bouchentouf M, Tremblay JP. Interleukin-4 improves the migration of human myogenic precursor cells in vitro and in vivo. Exp Cell Res 2006, 312:1127-1141. 10.1016/j.yexcr.2006.01.002, 16466711.
45. Olguin HC, Santander C, Brandan E. Inhibition of myoblast migration via decorin expression is critical for normal skeletal muscle differentiation. Dev Biol 2003, 259:209-224. 10.1016/S0012-1606(03)00180-5, 12871697.
46. Moscatelli D, Quarto N. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin. J Cell Biol 1989, 109:2519-2527. 10.1083/jcb.109.5.2519, 2115849, 2553749.
47. Rubin JS, Day RM, Breckenridge D, Atabey N, Taylor WG, Stahl SJ, Wingfield PT, Kaufman JD, Schwall R, Bottaro DP. Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling. J Biol Chem 2001, 276:32977-32983. 10.1074/jbc.M105486200, 11435444.
48. Roghani M, Moscatelli D. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem 1992, 267:22156-22162.
49. Zarnegar R, DeFrances MC, Oliver L, Michalopoulos G. Identification and partial characterization of receptor binding sites for HGF on rat hepatocytes. Biochem Biophys Res Commun 1990, 173:1179-1185. 10.1016/S0006-291X(05)80910-6, 2148475.
50. Lin X, Perrimon N. Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling. Nature 1999, 400:281-284. 10.1038/22343, 10421372.
51. Capurro MI, Xiang YY, Lobe C, Filmus J. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res 2005, 65:6245-6254. 10.1158/0008-5472.CAN-04-4244, 16024626.
52. Yan D, Lin X. Drosophila glypican Dally-like acts in FGF-receiving cells to modulate FGF signaling during tracheal morphogenesis. Dev Biol 2007, 312:203-216. 10.1016/j.ydbio.2007.09.015, 2151973, 17959166.
53. Filmus J, Capurro M, Rast J. Glypicans. Genome Biol 2008, 9:224. 10.1186/gb-2008-9-5-224, 2441458, 18505598.
54. Deakin JA, Lyon M. Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains. J Cell Sci 1999, 112:1999-2009.
55. Hartmann G, Prospero T, Brinkmann V, Ozcelik T, Winter G, Hepple J, Batley S, Bladt F, Sachs M, Birchmeier C, Birchmeier W, Gherardi E. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr Biol 1998, 8:125-134. 10.1016/S0960-9822(98)70059-4, 9443912.
56. Kemp LE, Mulloy B, Gherardi E. Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors. Biochem Soc Trans 2006, 34:414-417. 10.1042/BST0340414, 16709175.
57. Limpert AS, Karlo JC, Landreth GE. Nerve growth factor stimulates the concentration of TrkA within lipid rafts and extracellular signal-regulated kinase activation through c-Cbl-associated protein. Mol Cell Biol 2007, 27:5686-5698. 10.1128/MCB.01109-06, 1952120, 17548467.
58. Liu P, Ying Y, Ko YG, Anderson RG. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem 1996, 271:10299-10303. 10.1074/jbc.271.17.10299, 8626598.
59. Gao X, Zhang J. Akt signaling dynamics in plasma membrane microdomains visualized by FRET-based reporters. Commun Integr Biol 2009, 2:32-34. 10.4161/cib.2.1.7420, 2649297, 19704863.
60. Salani B, Briatore L, Contini P, Passalacqua M, Melloni E, Paggi A, Cordera R, Maggi D. IGF-I induced rapid recruitment of integrin β1 to lipid rafts is caveolin-1 dependent. Biochem Biophys Res Commun 2009, 380:489-492. 10.1016/j.bbrc.2009.01.102, 19250636.
61. Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae: a mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 2000, 275:41447-41457. 10.1074/jbc.M006951200, 11006286.
62. Chun M, Liyanage UK, Lisanti MP, Lodish HF. Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc Natl Acad Sci U S A 1994, 91:11728-11732. 10.1073/pnas.91.24.11728, 45305, 7972131.
63. Monastyrskaya K, Hostettler A, Buergi S, Draeger A. The NK1 receptor localizes to the plasma membrane microdomains, and its activation is dependent on lipid raft integrity. J Biol Chem 2005, 280:7135-7146. 10.1074/jbc.M405806200, 15590676.
64. Dessy C, Kelly RA, Balligand JL, Feron O. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J 2000, 19:4272-4280. 10.1093/emboj/19.16.4272, 302031, 10944110.
65. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat Cell Biol 2003, 5:410-421. A published erratum appears in Nat Cell Biol 2003, 5:680, 10.1038/ncb975, 12717440.
66. Mineo C, Gill GN, Anderson RG. Regulated migration of epidermal growth factor receptor from caveolae. J Biol Chem 1999, 274:30636-30643. 10.1074/jbc.274.43.30636, 10521449.
67. Nakamura T, Sakai K, Matsumoto K. Hepatocyte growth factor twenty years on: much more than a growth factor. J Gastroenterol Hepatol 2011, 26(Suppl 1):188-202.
68. Franz T, Kothary R, Surani MA, Halata Z, Grim M. The Splotch mutation interferes with muscle development in the limbs. Anat Embryol (Berl) 1993, 187:153-160.
69. Bober E, Brand-Saberi B, Ebensperger C, Wilting J, Balling R, Paterson BM, Arnold HH, Christ B. Initial steps of myogenesis in somites are independent of influence from axial structures. Development 1994, 120:3073-3082.
70. Daston G, Lamar E, Olivier M, Goulding M. Pax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse. Development 1996, 122:1017-1027.
71. Huard J, Bouchard JP, Roy R, Malouin F, Dansereau G, Labrecque C, Albert N, Richards CL, Lemieux B, Tremblay JP. Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve 1992, 15:550-560. 10.1002/mus.880150504, 1584246.
72. Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 1993, 2:99-112.
73. Miller RG, Sharma KR, Pavlath GK, Gussoni E, Mynhier M, Lanctot AM, Greco CM, Steinman L, Blau HM. Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve 1997, 20:469-478. 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.0.CO;2-U, 9121505.
74. Cornelison DD, Filla MS, Stanley HM, Rapraeger AC, Olwin BB. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev Biol 2001, 239:79-94. 10.1006/dbio.2001.0416, 11784020.
75. Galbiati F, Volonte D, Engelman JA, Scherer PE, Lisanti MP. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts: transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J Biol Chem 1999, 274:30315-30321. 10.1074/jbc.274.42.30315, 10514527.
76. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996, 271:15292-15297. 10.1074/jbc.271.25.15292, 8663044.
77. Yamada M, Tatsumi R, Yamanouchi K, Hosoyama T, Shiratsuchi S, Sato A, Mizunoya W, Ikeuchi Y, Furuse M, Allen RE. High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: a possible mechanism for reestablishing satellite cell quiescence in vivo. Am J Physiol Cell Physiol 2010, 298:C465-C476. 10.1152/ajpcell.00449.2009, 2838568, 20007454.
78. Gill R, Hitchins L, Fletcher F, Dhoot GK. Sulf1A and HGF regulate satellite-cell growth. J Cell Sci 2010, 123:1873-1883. 10.1242/jcs.061242, 2873224, 20442248.
79. Larraín J, Cizmeci-Smith G, Troncoso V, Stahl RC, Carey DJ, Brandan E. Syndecan-1 expression is down-regulated during myoblast terminal differentiation: modulation by growth factors and retinoic acid. J Biol Chem 1997, 272:18418-18424. 10.1074/jbc.272.29.18418, 9218485.
80. Casar JC, Cabello-Verrugio C, Olguin H, Aldunate R, Inestrosa NC, Brandan E. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation. J Cell Sci 2004, 117:73-84. 10.1242/jcs.00828, 14627628.
81. Jen YH, Musacchio M, Lander AD. Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis. Neural Dev 2009, 4:33. 10.1186/1749-8104-4-33, 2746204, 19732411.
82. Anastasi S, Giordano S, Sthandier O, Gambarotta G, Maione R, Comoglio P, Amati P. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation. J Cell Biol 1997, 137:1057-1068. 10.1083/jcb.137.5.1057, 2136220, 9166406.
83. Allen RE, Sheehan SM, Taylor RG, Kendall TL, Rice GM. Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J Cell Physiol 1995, 165:307-312. 10.1002/jcp.1041650211, 7593208.
84. Tatsumi R, Anderson JE, Nevoret CJ, Halevy O, Allen RE. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol 1998, 194:114-128. 10.1006/dbio.1997.8803, 9473336.
85. Tatsumi R, Hattori A, Ikeuchi Y, Anderson JE, Allen RE. Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide. Mol Biol Cell 2002, 13:2909-2918. 10.1091/mbc.E02-01-0062, 117951, 12181355.
86. Wozniak AC, Pilipowicz O, Yablonka-Reuveni Z, Greenway S, Craven S, Scott E, Anderson JE. C-Met expression and mechanical activation of satellite cells on cultured muscle fibers. J Histochem Cytochem 2003, 51:1437-1445. 10.1177/002215540305101104, 14566016.
87. Zammit PS, Golding JP, Nagata Y, Hudon V, Partridge TA, Beauchamp JR. Muscle satellite cells adopt divergent fates: a mechanism for self-renewal?. J Cell Biol 2004, 166:347-357. 10.1083/jcb.200312007, 2172269, 15277541.
88. Zammit PS. All muscle satellite cells are equal, but are some more equal than others?. J Cell Sci 2008, 121:2975-2982. 10.1242/jcs.019661, 18768931.
89. Pallafacchina G, Francois S, Regnault B, Czarny B, Dive V, Cumano A, Montarras D, Buckingham M. An adult tissue-specific stem cell in its niche: a gene profiling analysis of in vivo quiescent and activated muscle satellite cells. Stem Cell Res 2010, 4:77-91. 10.1016/j.scr.2009.10.003, 19962952.
90. Kuang S, Gillespie MA, Rudnicki MA. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2008, 2:22-31. 10.1016/j.stem.2007.12.012, 18371418.
91. Cossu G, Tajbakhsh S. Oriented cell divisions and muscle satellite cell heterogeneity. Cell 2007, 129:859-861. 10.1016/j.cell.2007.05.029, 17540166.